Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | SAR260301 |
Trade Name | |
Synonyms | SAR 260301|SAR-260301 |
Drug Descriptions |
SAR260301 is PI3K beta-selective inhibitor, which has been demonstrated to inhibit tumor growth in xenograft models (PMID: 24387221, PMID: 28976556). |
DrugClasses | PIK3CB inhibitor 8 |
CAS Registry Number | 1260612-13-2 |
NCIT ID | C116882 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
SAR260301 | SAR260301 | 4 | 1 |
SAR260301 + Selumetinib | SAR260301 Selumetinib | 1 | 0 |
SAR260301 + Vemurafenib | SAR260301 Vemurafenib | 1 | 1 |